The second PLS analysis identified a sole significant LV (p = 0.0002), which accounted for 47.18% of the covariance in the GRS-brain data and differentiated among brain markers of genetic risk for MDD, as well as APOE- vs no-APOE-linked vulnerability to AD (Fig. 2d). The gene discussed is APOE; the disease is Alzheimer disease.